Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

5 Apr 2016 07:00

RNS Number : 1289U
Electrocomponents PLC
05 April 2016
 

Electrocomponents plc today issues a trading update for the year ended 31 March 2016, ahead of publishing full-year results on 19 May 2016.

 

 

Sales growth(1)

 

 

 

Region

Quarter to Mar 2016

Year to Mar 2016

 

UK

 

4%

 

0%

Continental Europe

8%

11%

North America

-4%

-2%

Asia Pacific

-8%

-2%

Group

2%

3%

 

 

 

· We anticipate that Group headline profit before tax (2) for the full year will be around the top end of market expectations (3).

· In the final quarter Group underlying sales growth (1) was 2%, leading to 3% revenue growth for the full year.

· UK recovery gained pace with 4% (4) growth in the period.

· Continental Europe continued to see strong growth of 8% during the period with all major markets performing well.

· North America saw declines moderate to 4% aided in part by easier comparatives.

· Asia Pacific revenues were down 8% as we saw the anticipated disruption impact of the significant restructuring we are carrying out in the region.

· In the final quarter we have continued to see a stabilisation in the gross margin with the year-on-year decline reducing to 0.4% points. As a result, we expect full-year gross margin to be down around 1% point year on year.

· We remain on track to deliver the targeted £25 million annualised savings, with at least£6 million delivered in the year to March 2016.

 

 

Enquiries:

 

 

 

David Egan

Group Finance Director

01865 204000

Polly Elvin

Investor Relations and Corporate PR

01865 207427

David Allchurch / Martin Robinson

Tulchan Communications

020 7353 4200

Notes:

 

(1) Sales growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying sales growth/decline").

(2) Full-year headline profit before tax is expected to be positively impacted by around£1 million due to the impact of one extra average trading day (H1 2016 impact: £0 million).

(3) The consensus for full-year headline profit before tax is £73.1 million (the consensus PBT range is £71.8 million to £74.5 million).

(4) UK excluding Raspberry Pi revenue growth was 2% in Q4 and -1% FY.

(5) Our profits remain sensitive to movements in exchange rates on translation of overseas profits. Every one cent movement in the Euro will have a £0.5 million impact on profits. Every one cent movement in US $ will have a £0.2 million impact on profits.

(6) Reported 2015 full-year headline profit before tax of £80.1 million would be around£3 million lower if translated at year to March 2016 average exchange rates.

(7) As announced in November, we are restating our results to show the profit and loss split for our five operating regions: Northern Europe, Central Europe, Southern Europe, North America and Asia Pacific. Fully restated regional breakdowns for the year to 31 March 2015 and the half year to November 2015 will be available in the investor section of our website by the end of April.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSUNRNWASRAR
Date   Source Headline
28th Jun 202110:00 amRNSNotice of Trading Update
25th Jun 20212:30 pmRNSDirector/PDMR Shareholding
17th Jun 202111:00 amRNSDirector/PDMR Shareholding
15th Jun 202112:00 pmRNSAnnual Financial Report
10th Jun 202111:00 amRNSDirector/PDMR Shareholding
1st Jun 20219:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSFinal Results
24th May 20213:00 pmRNSHolding(s) in Company
4th May 20213:00 pmRNSDirector Declaration
4th May 20219:00 amRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20219:00 amRNSTotal Voting Rights
30th Mar 202110:00 amRNSNotice of Trading Update
18th Mar 20212:30 pmRNSDirector/PDMR Shareholding
10th Mar 202110:00 amRNSAdditional Listing
1st Mar 20214:00 pmRNSDirector Declaration
1st Mar 202110:00 amRNSTotal Voting Rights
1st Mar 20217:00 amRNSAcquisition of John Liscombe Limited
8th Feb 20217:00 amRNSTrading Statement
4th Feb 202110:00 amRNSHolding(s) in Company
2nd Feb 20212:30 pmRNSDirector/PDMR Shareholding
1st Feb 20219:01 amRNSBlock listing Interim Review
1st Feb 20219:00 amRNSTotal Voting Rights
27th Jan 202110:00 amRNSNotice of Trading Update
13th Jan 20217:00 amRNSCompletion of Synovos acquisition
4th Jan 202110:46 amRNSTotal Voting Rights
21st Dec 20202:30 pmRNSDirector/PDMR Shareholding
16th Dec 20209:30 amRNSHolding(s) in Company
15th Dec 20202:35 pmRNSHolding(s) in Company
11th Dec 202011:00 amRNSDirectorate Change
10th Dec 20204:17 pmRNSResults of the Placing
10th Dec 20207:20 amRNSRetail Offer via PrimaryBid.com
10th Dec 20207:18 amRNSProposed Placing of Ordinary Shares
10th Dec 20207:14 amRNSStrategically Attractive Acquisitions and Placing
4th Dec 202010:00 amRNSHolding(s) in Company
3rd Dec 20204:05 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
20th Nov 202010:30 amRNSDirector/PDMR Shareholding
20th Nov 202010:30 amRNSRefinancing of Group Debt facilities
17th Nov 20203:25 pmRNSHolding(s) in Company
17th Nov 20202:30 pmRNSAdditional Listing
12th Nov 202011:28 amRNSDirector/PDMR Shareholding
10th Nov 202010:00 amRNSDividend Declaration
10th Nov 20207:00 amRNSHalf-year Report
2nd Nov 202010:30 amRNSTotal Voting Rights
8th Oct 20207:00 amRNSTrading Statement
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 202010:00 amRNSTotal Voting Rights
21st Sep 202010:30 amRNSNotice of Trading Update
18th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.